Literature DB >> 20010440

Primary malignant melanoma of the esophagus.

Xueying Yang1, Jiaqi Qu, Shumin Wang.   

Abstract

Primary malignant melanoma of the esophagus is an extremely rare, but highly aggressive, tumor. The prognosis for primary malignant melanoma of the esophagus remains dismal in most literatures. We report here a case of primary malignant melanoma of the esophagus that was treated by surgical resection and, additionally, followed by chemotherapy. The clinical features, treatment, pathological findings, and prognosis are analyzed and the literature of primary malignant melanoma of the esophagus is reviewed.

Entities:  

Mesh:

Year:  2010        PMID: 20010440     DOI: 10.1097/CMR.0b013e3283307c8a

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

Review 1.  The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus.

Authors:  Gerardo Cazzato; Eliano Cascardi; Anna Colagrande; Teresa Lettini; Leonardo Resta; Cinzia Bizzoca; Francesca Arezzo; Vera Loizzi; Miriam Dellino; Gennaro Cormio; Nadia Casatta; Carmelo Lupo; Antonio Scillimati; Salvatore Scacco; Paola Parente; Lucia Lospalluti; Giuseppe Ingravallo
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575

2.  Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review.

Authors:  Sheng-Li Zhou; Lian-Qun Zhang; Xue-Ke Zhao; Yue Wu; Qiu-Yu Liu; Bo Li; Jian-Jun Wang; Rui-Jiao Zhao; Xi-Juan Wang; Yi Chen; Li-Dong Wang; Ling-Fei Kong
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

3.  Primary malignant melanoma of the esophagus: a rare and aggressive disease.

Authors:  Flávio Hiroshi Ananias Morita; Ulysses Ribeiro; Rubens Antonio Aissar Sallum; Marcos Roberto Tacconi; Flávio Roberto Takeda; Julio Rafael Mariano da Rocha; Giovanna de Sanctis Callegari Ligabó; Evandro Sobrosa de Melo; Wilson Modesto Pollara; Ivan Cecconello
Journal:  World J Surg Oncol       Date:  2013-08-23       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.